Skip to main content

Lazard, Inc. (LAZ) Stock Forecast 2025 - AI Price Prediction & Analysis


Lazard, Inc. (LAZ) AI Stock Price Forecast & Investment Analysis

Lazard, Inc. Stock Price Chart and Technical Analysis

Loading Lazard, Inc. interactive price chart and technical analysis...

Lazard, Inc. (LAZ) - Comprehensive Stock Analysis & Investment Research

Deep dive into Lazard, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Lazard, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Lazard, Inc.: Lazard, Inc. operates in the Finance sector, establishing it as a mid-cap growth opportunity.

Lazard, Inc. (Stock Symbol: LAZ) is a leading company in the Finance sector , specifically operating within the Investment Advice industry.

The organization employs approximately 4027 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Lazard, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Lazard, Inc.: With $3132M in annual revenue and 8.2% net margin, the company demonstrates solid profitability.

Annual Revenue: $3132 million generating a 8.2% net profit margin .

Market Capitalization: $6911 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 67.6% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Lazard, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Lazard, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Lazard, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Lazard, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Lazard, Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

Lazard, Inc. strategically competes in the highly dynamic Investment Advice marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $730 million annually, complemented by impressive -15.1% year-over-year cash flow growth.

The company maintains a healthy 40.4% gross margin, indicating strong pricing power and operational efficiency.

Lazard, Inc. (LAZ) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Lazard, Inc. stock analysis.

Loading Lazard, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Lazard, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Lazard, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Lazard, Inc.: With a P/E ratio of 22.30, the market moderately values the company's earnings.

P/E Ratio 22.30x
P/B Ratio 9.32x
Market Cap $6911M
Dividend Yield 3.56%
EPS $3.19
Book Value/Share $6.03
Revenue/Share $25.46
FCF/Share $5.12
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Lazard, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Lazard, Inc.: An ROE of 67.6% demonstrates excellent shareholder value creation.

ROE 67.6%
ROA 8.4%
ROIC 17.9%
Gross Margin 40.4%
Operating Margin 11.2%
Net Margin 8.2%
EBT Margin 22.6%
Tax Rate 23.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Lazard, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Lazard, Inc.: A current ratio of 2.26 indicates strong liquidity.

Current Ratio 2.26x
Quick Ratio 1.90x
D/E Ratio 2.62x
Financial Leverage 8.06x
Working Capital $1933M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Lazard, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Lazard, Inc.: Free cash flow of $730M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $776M
Free Cash Flow $730M
Capital Spending $-46M
OCF Growth YoY -15.1%
FCF Growth YoY -19.5%
FCF/Sales 22.1%
CapEx/Sales 1.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Lazard, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Lazard, Inc.: An asset turnover of 0.51x suggests room for improvement in asset utilization.

Asset Turnover 0.51x
Receivables Turnover 4.3x
Fixed Assets Turnover 4.6x
Days Sales Outstanding 86 days
Payables Period 37 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Lazard, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Lazard, Inc.: With annual revenue of $3132M, Lazard, Inc. operates at significant scale.

Income Statement ($ Millions)
Total Revenue $3132M
SG&A Expense $8M
Cost of Goods Sold $60M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 58%
Cash & Short-term Investments 37%
Total Liabilities 86%
Accounts Receivable 12%
Dividend & Shareholder Information
Dividends Per Share $2.00
Payout Ratio 0.6%
Shares Outstanding 123M
Growth Metrics (YoY)
EPS Growth 4.7%

Latest Lazard, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Lazard, Inc. (LAZ) stock price and investment outlook.

📰 We are currently updating our news feed for Lazard, Inc.. Check back soon for the latest market analysis and company updates.

Lazard, Inc. Competitors & Peer Analysis - Finance Sector

Comparative analysis of Lazard, Inc. against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAMI Unlock Forecast - 30 Days FREE Trial $M x x
AB Unlock Forecast - 30 Days FREE Trial $0M 11.6x 0.0x
ABL Unlock Forecast - 30 Days FREE Trial $652M -396.0x 1.6x
ABLLL Unlock Forecast - 30 Days FREE Trial $2473M -1421.2x 5.9x
ABLLW Unlock Forecast - 30 Days FREE Trial $78M x -4.3x
ALTI Unlock Forecast - 30 Days FREE Trial $0M -2.2x 0.0x
AMG Unlock Forecast - 30 Days FREE Trial $10318M 23.3x 3.2x
AMP Unlock Forecast - 30 Days FREE Trial $49038M 15.2x 8.1x
APAM Unlock Forecast - 30 Days FREE Trial $5957M 22.0x 15.6x
APO Unlock Forecast - 30 Days FREE Trial $139386M 41.4x 7.2x
APO-PA Unlock Forecast - 30 Days FREE Trial $72130M 21.4x 3.7x
APOS Unlock Forecast - 30 Days FREE Trial $27458M 8.2x 1.4x
ARES Unlock Forecast - 30 Days FREE Trial $114467M 246.8x 32.3x
ARES-PB Unlock Forecast - 30 Days FREE Trial $35869M 77.4x 10.1x
BAM Unlock Forecast - 30 Days FREE Trial $22352M x 10.8x
BEN Unlock Forecast - 30 Days FREE Trial $15059M 46.7x 1.2x
BRDG Unlock Forecast - 30 Days FREE Trial $2070M -43.6x 27.6x
BSIG Unlock Forecast - 30 Days FREE Trial $0M 18.8x 0.0x
BX Unlock Forecast - 30 Days FREE Trial $123068M 67.2x 15.4x
CG Unlock Forecast - 30 Days FREE Trial $21574M -285.9x 3.0x
CGABL Unlock Forecast - 30 Days FREE Trial $6378M -88.4x 1.4x
CNS Unlock Forecast - 30 Days FREE Trial $3706M 38.5x 7.3x
DBRG Unlock Forecast - 30 Days FREE Trial $2352M 43.5x 1.2x
DBRG-PH Unlock Forecast - 30 Days FREE Trial $4717M 87.2x 2.3x
DBRG-PI Unlock Forecast - 30 Days FREE Trial $4657M 86.0x 2.3x
DBRG-PJ Unlock Forecast - 30 Days FREE Trial $4646M 85.8x 2.3x
DHIL Unlock Forecast - 30 Days FREE Trial $443M 9.2x 2.6x
ENDI Unlock Forecast - 30 Days FREE Trial $95M x 4.3x
EVR Unlock Forecast - 30 Days FREE Trial $15700M 34.0x 9.5x
FHI Unlock Forecast - 30 Days FREE Trial $0M 14.4x 0.0x
GCMG Unlock Forecast - 30 Days FREE Trial $4211M 152.2x 0.0x
GCMGW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
GROW Unlock Forecast - 30 Days FREE Trial $0M 24.4x 0.0x
HKHC Unlock Forecast - 30 Days FREE Trial $3991M 37.7x 11.4x
HLI Unlock Forecast - 30 Days FREE Trial $0M 38.5x 0.0x
HLNE Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
HNNA Unlock Forecast - 30 Days FREE Trial $97M 15.8x 1.0x
HNNAZ Unlock Forecast - 30 Days FREE Trial $198M 32.4x 2.1x
ILLR Unlock Forecast - 30 Days FREE Trial $24M -4.4x -31.3x
ILLRW Unlock Forecast - 30 Days FREE Trial $24M x -4.1x
IVZ Unlock Forecast - 30 Days FREE Trial $8996M -46.3x 0.6x
JHG Unlock Forecast - 30 Days FREE Trial $6550M 16.5x 1.4x
KKR Unlock Forecast - 30 Days FREE Trial $307839M 150.1x 10.9x
KKR-PD Unlock Forecast - 30 Days FREE Trial $120725M 58.9x 4.3x
KKRS Unlock Forecast - 30 Days FREE Trial $42348M 20.7x 1.5x
KKRT Unlock Forecast - 30 Days FREE Trial $57942M 28.3x 2.1x
LAZ Unlock Forecast - 30 Days FREE Trial $6911M 22.3x 9.3x
MAAS Unlock Forecast - 30 Days FREE Trial $M x x
MC Unlock Forecast - 30 Days FREE Trial $0M 7.6x 0.0x
MGR Unlock Forecast - 30 Days FREE Trial $989M 2.2x 0.3x
MGRB Unlock Forecast - 30 Days FREE Trial $826M 1.9x 0.3x
MGRD Unlock Forecast - 30 Days FREE Trial $740M 1.7x 0.2x
MGRE Unlock Forecast - 30 Days FREE Trial $1122M 2.5x 0.4x
MORN Unlock Forecast - 30 Days FREE Trial $12263M 56.0x 17.9x
NOAH Unlock Forecast - 30 Days FREE Trial $349M x 1.6x
OAK-PA Unlock Forecast - 30 Days FREE Trial $5671M 18.4x 2.4x
OAK-PB Unlock Forecast - 30 Days FREE Trial $5692M 18.5x 2.4x
OWL Unlock Forecast - 30 Days FREE Trial $0M 149.1x 0.0x
PJT Unlock Forecast - 30 Days FREE Trial $0M 29.0x 0.0x
PX Unlock Forecast - 30 Days FREE Trial $1681M 115.2x 5.0x
RILY Unlock Forecast - 30 Days FREE Trial $90M -0.6x -0.2x
RILYG Unlock Forecast - 30 Days FREE Trial $310M -1.6x -0.6x
RILYK Unlock Forecast - 30 Days FREE Trial $626M -2.4x -1.3x
RILYL Unlock Forecast - 30 Days FREE Trial $73M -0.9x -0.2x
RILYM Unlock Forecast - 30 Days FREE Trial $766M -2.8x -1.5x
RILYN Unlock Forecast - 30 Days FREE Trial $352M -1.6x -0.7x
RILYP Unlock Forecast - 30 Days FREE Trial $80M -0.9x -0.2x
RILYT Unlock Forecast - 30 Days FREE Trial $214M -1.3x -0.4x
RILYZ Unlock Forecast - 30 Days FREE Trial $196M -1.2x -0.4x
SAMG Unlock Forecast - 30 Days FREE Trial $0M 17.9x 0.0x
STEP Unlock Forecast - 30 Days FREE Trial $53059M 109.3x 344.7x
TPG Unlock Forecast - 30 Days FREE Trial $78221M 1256.1x 78.9x
TPGXL Unlock Forecast - 30 Days FREE Trial $34327M 551.2x 34.6x
TROW Unlock Forecast - 30 Days FREE Trial $26548M 13.0x 2.5x
VALU Unlock Forecast - 30 Days FREE Trial $0M 20.7x 0.0x
VCTR Unlock Forecast - 30 Days FREE Trial $4775M 17.1x 1.9x
VRTS Unlock Forecast - 30 Days FREE Trial $1561M 10.7x 1.7x
WHG Unlock Forecast - 30 Days FREE Trial $153M 27.8x 1.3x

Frequently Asked Questions - Lazard, Inc. Stock Forecast

How accurate are Lazard, Inc. stock predictions?

Our AI model demonstrates 57% historical accuracy for LAZ predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Lazard, Inc. stock price forecasts?

Our analysis considers Lazard, Inc.'s financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Lazard, Inc. a good investment in 2025?

Based on our AI analysis, Lazard, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Lazard, Inc. forecasts updated?

Lazard, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Lazard, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Lazard, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...